Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.

Acta neuropathologica communications - 22 Aug 2016

Araki Asuka, Chocholous Monika, Gojo Johannes, Dorfer Christian, Czech Thomas, Heinzl Harald, Dieckmann Karin, Ambros Inge M, Ambros Peter F, Slavc Irene, Haberler Christine

Abstract excerpt

Intracranial classic (WHO grade II) and anaplastic (WHO grade III) ependymomas are among the most common tumors in pediatric patients and have due to frequent recurrences and late relapses a relatively poor outcome. The impact of histopathological grading on patient outcome is controversial and therefore, molecular prognostic and predictive markers are needed to improve patient outcome. To date, the most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Chromosome Duplication

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 1

Share to Ependymoma

Share to Laminin

Share to Neoplasm Grading

Share to Survival Analysis

Share to Tenascin

Source

Open in PubMed Open full text

Identifiers

PMID: 27550150
DOI: 10.1186/s40478-016-0349-9
PMCID: PMC4994287

Genes

TNC
LAMA2
NELL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.PMID 27550150Read ↗

Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial EpendymomaSemantic proximity Read ↗

Review of molecular classification and treatment implications of pediatric brain tumors.Semantic proximity Read ↗

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohortSemantic proximity Read ↗

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).Semantic proximity Read ↗

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.Semantic proximity Read ↗

Pediatric Brain TumorsSemantic proximity Read ↗

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsSemantic proximity Read ↗

Pediatric Ependymoma: Biological PerspectivesSemantic proximity Read ↗

Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.Semantic proximity Read ↗

The Emerging Molecular Foundations of Pediatric Brain TumorsSemantic proximity Read ↗

Advances in the classification and treatment of pediatric brain tumors.Semantic proximity Read ↗

Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.